| 1 |
22816019 | ACS chemical neuroscience molecule spotlight on Telcagepant (MK-0974). | 2011 Jul 20 |
2 |
| 2 |
19914210 | Non-peptidic antagonists of the CGRP receptor, BIBN4096BS and MK-0974, interact with the calcitonin receptor-like receptor via methionine-42 and RAMP1 via tryptophan-74. | 2010 Jan 1 |
1 |
| 3 |
20078608 | Inhibition of capsaicin-induced increase in dermal blood flow by the oral CGRP receptor antagonist, telcagepant (MK-0974). | 2010 Jan |
2 |
| 4 |
20573757 | Characterization of the calcitonin gene-related peptide receptor antagonist telcagepant (MK-0974) in human isolated coronary arteries. | 2010 Sep 1 |
1 |
| 5 |
19084002 | Examining the binding properties of MK-0974: a CGRP receptor antagonist for the acute treatment of migraine. | 2009 Jan 14 |
4 |
| 6 |
17914062 | Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine. | 2008 Apr 15 |
5 |
| 7 |
18039958 | Pharmacological characterization of MK-0974 [N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide], a potent and orally active calcitonin gene-related peptide receptor antagonist for the treatment of migraine. | 2008 Feb |
4 |
| 8 |
18217201 | Treatment of migraine attacks based on the interaction with the trigemino-cerebrovascular system. | 2008 Feb |
1 |
| 9 |
18759547 | Proinflammatory mediators and migraine pathogenesis: moving towards CGRP as a target for a novel therapeutic class. | 2008 Sep |
1 |
| 10 |
18991732 | The tortuous road to an ideal CGRP function blocker for the treatment of migraine. | 2008 |
2 |
| 11 |
19036425 | Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial. | 2008 Dec 20 |
1 |
| 12 |
17963849 | CGRP antagonists: unravelling the role of CGRP in migraine. | 2007 Nov |
1 |